Gianni Sava Selected Research

Ions

4/2011

Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianni Sava Research Topics

Disease

33	Neoplasms (Cancer) 06/2023 - 07/2002
27	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2002
11	Carcinoma (Carcinomatosis) 10/2015 - 02/2003
4	Breast Neoplasms (Breast Cancer) 08/2017 - 12/2008
4	Adenocarcinoma 11/2007 - 01/2003
3	Thrombosis (Thrombus) 01/2022 - 01/2021
3	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2021
3	COVID-19 01/2022 - 01/2021
3	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 10/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 01/2021
2	Hemorrhage 12/2021 - 01/2021
2	Fatigue 02/2021 - 02/2015
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 10/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2015 - 08/2004
2	Lewis Lung Carcinoma 05/2003 - 02/2003
1	Virus Diseases (Viral Diseases) 01/2024
1	Myocardial Infarction 12/2021
1	Stroke (Strokes) 12/2021
1	Leukemia 01/2021
1	Neutropenia 02/2015
1	Nausea 02/2015
1	Anemia 02/2015
1	Constipation 02/2015
1	Vomiting 02/2015
1	Diarrhea 02/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2014
1	Hyperglycemia 03/2014
1	Body Weight (Weight, Body) 01/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2008
1	Melanoma (Melanoma, Malignant) 04/2008

Drug/Important Bio-Agent (IBA)

26	RutheniumIBA 01/2021 - 07/2002
25	imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)IBA 01/2021 - 07/2002
6	Proteins (Proteins, Gene)FDA Link 01/2016 - 05/2003
6	MetalsIBA 01/2016 - 12/2004
5	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 05/2008 - 02/2003
3	Muramidase (Lysozyme)IBA 01/2024 - 11/2008
3	BNT162 VaccineIBA 01/2022 - 01/2021
3	ChAdOx1 nCoV-19IBA 01/2022 - 01/2021
3	VaccinesIBA 01/2022 - 01/2021
3	PlatinumIBA 01/2019 - 04/2011
3	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 08/2004
3	RAPTA-TIBA 08/2017 - 12/2008
3	CollagenIBA 10/2015 - 05/2003
3	LigandsIBA 07/2012 - 08/2004
3	Cisplatin (Platino)FDA LinkGeneric 04/2011 - 07/2006
3	Butyric Acid (Butanoic Acid)IBA 05/2008 - 07/2004
3	Hyaluronic Acid (Hyaluronan)IBA 05/2008 - 07/2004
3	matrigelIBA 02/2004 - 12/2002
2	Platelet Factor 4IBA 01/2022 - 01/2021
2	AntibodiesIBA 01/2022 - 01/2021
2	EnzymesIBA 01/2019 - 02/2015
2	IntegrinsIBA 01/2016 - 10/2015
2	Coordination ComplexesIBA 12/2015 - 04/2011
2	RNA (Ribonucleic Acid)IBA 10/2015 - 12/2013
2	CreatinineIBA 02/2015 - 01/2013
2	Gemcitabine FDA Link 02/2015 - 02/2015
2	FullerenesIBA 01/2015 - 12/2013
2	Histone Deacetylase InhibitorsIBA 05/2008 - 07/2004
2	GelatinasesIBA 10/2004 - 02/2004
2	Peptide Hydrolases (Proteases)FDA Link 01/2004 - 05/2003
1	Disinfectants (Biocides)IBA 01/2024
1	Antiviral Agents (Antivirals)IBA 01/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2023
1	Messenger RNA (mRNA)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Ad26COVS1IBA 12/2021
1	ResveratrolIBA 02/2021
1	Organometallic CompoundsIBA 01/2019
1	3-hydroxycholest-7-ene-14-carbaldehydeIBA 01/2017
1	Ruthenium CompoundsIBA 08/2016
1	Integrin alpha5beta1IBA 01/2016
1	Platinum Compounds (Compounds, Platinum)IBA 12/2015
1	Fibronectins (Fibronectin)IBA 10/2015
1	Transcription Factors (Transcription Factor)IBA 10/2015
1	Conditioned Culture MediaIBA 10/2015
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2015
1	Investigational DrugsIBA 02/2015
1	NitrogenIBA 01/2015
1	Advanced Glycation End ProductsIBA 03/2014
1	Caspase 8 (Caspase-8)IBA 12/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2012
1	IonsIBA 04/2011
1	GoldIBA 04/2011
1	TolueneIBA 12/2008
1	Ethylene Glycol (Monoethylene Glycol)IBA 11/2008
1	Caspase 7IBA 05/2008
1	SurvivinIBA 05/2008
1	Cyclin D1IBA 05/2008
1	Vascular Endothelial Growth Factor DIBA 05/2008
1	Vascular Endothelial Growth Factor CIBA 05/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2008
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 05/2008
1	ChloridesIBA 04/2008
1	Heavy MetalsIBA 07/2006
1	Protein Isoforms (Isoforms)IBA 10/2004

Therapy/Procedure

4	Therapeutics 12/2015 - 12/2002
2	Drug Therapy (Chemotherapy) 06/2023 - 12/2015
1	Oral Administration 11/2008